Anjali Chutke

Title: Anjali Chutke: Innovator in Biopharmaceutical Purification

Introduction

Anjali Chutke is a prominent inventor based in Mumbai, India. She has made significant contributions to the field of biopharmaceuticals, particularly in the purification of recombinant human parathyroid hormone (rhPTH). Her innovative approach has led to advancements in the production of this important therapeutic protein.

Latest Patents

Anjali holds a patent for an "Orthogonal process for purification of recombinant human parathyroid hormone (rhPTH) (1-34)." This invention outlines a novel method for preparing rhPTH (1-34), also known as teriparatide, through the construction of a unique nucleotide fragment. The process involves cloning this nucleotide in an expression vector, transforming it, and expressing the chimeric fusion protein in fed batch fermentation. Furthermore, her invention introduces a two-step orthogonal purification process that achieves a target protein purity of ≥99%, making it a simple, cost-effective, and environmentally friendly method for producing high-purity rhPTH (1-34).

Career Highlights

Anjali Chutke is currently employed at USV Private Limited, where she continues to work on innovative solutions in the biopharmaceutical sector. Her expertise in protein purification and bioprocessing has positioned her as a valuable asset to her organization.

Collaborations

Anjali collaborates with talented professionals such as Rakesh Shekhawat and Gulnaz Zaidi. Their combined efforts contribute to the advancement of biopharmaceutical technologies and the development of effective therapeutic solutions.

Conclusion

Anjali Chutke's work in the purification of recombinant human parathyroid hormone exemplifies her innovative spirit and dedication to improving biopharmaceutical processes. Her contributions are paving the way for more efficient and environmentally friendly methods in the industry.